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Founder Effect, Seen in the British Population, of the
172 Peripherin/RDS Mutation—and Further
Refinement of Genetic Positioning
of the Peripherin/RDS Gene
To the Editor:
Peripherin/retinal degeneration slow (RDS) is a
membrane-associated glycoprotein found in the outer
segments of retinal rod and cone photoreceptor cells. It
is thought to play a role in membrane structural stabi-
lization, in conjunction with retinal outer segment
membrane protein 1 (ROM1).
Mutations in the RDS gene give rise to retinal degen-
erations with a wide phenotypic spectrum. The majority
of mutations result in macular dystrophies (reviewed in
Keen and Inglehearn 1996). Specific mutations in the
RDS gene may lead to a wide inter- and intrafamilial
variability of phenotype, as seen in one family with ret-
initis pigmentosa, pattern dystrophy, and fundus flavi-
maculatus, in three different members with a deletion at
codon 153/154. (Weleber et al. 1993)
Mutation analysis by heteroduplex and direct se-
quencing of PCR-amplified coding exons of the RDS
gene was performed in 300 British patients with dom-
inantly inherited macular dystrophies; 7.3% of this
group had peripherin/RDS mutations, segregating with
disease. One particular mutation accounted for 11 of
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Table 1
Peripherin/RDS Mutations Carried by 10
Families That Do Not Have a 172 Mutation
Mutation
Number Mutation Phenotype
1 220ArgrTrp Pattern dystrophy
2 213CysrArg Pattern dystrophy
3 234ins (1 bp) Pattern dystrophy
4 258Tyrrstop Pattern dystrophya
5 210ProrArg Pattern dystrophy
6 224ins (37 bp) Adult vitelliform
7 140ins (1 bp) Pattern dystrophyb
8 219ProrArg Macular dystrophy
9 221ArgrGln Pattern dystrophy
10 87del (8 bp) Pattern dystrophy
a Previously reported by Wells et al. (1993).
b Previously reported by Keen et al. (1994).
Table 2
Ancestral Disease Haplotype Shared by 11 Families That Have the 172ArgrTrp Mutation in Peripherin/RDS, Compared with Ancestral
Disease Haplotype of a Family That Has the 172ArgrGln Mutation
MARKER
HAPLOTYPE IN FAMILIES WITH 172ARGrTRP MUTATION
HAPLOTYPE
IN FAMILY
WITH
172ARGrGLN
MUTATION
Family
1
Family
2
Family
3
Family
4
Family
5
Family
6
Family
7
Family
8
Family
9
Family
10
Family
11
D6S258 3 3 3 3 3 6 6 6 6 2 2 4
D6S276 2 6 6 7 7 7 7 7 7 7 5 5
D6S291 1 1 1 1 1 1 1 1 1 1 1 2
D6S271 5 5 5 5 5 5 5 5 5 5 5 1
D6S282 3 3 3 3 3 3 3 3 3 3 3 3
D6S459 2 2 2 2 2 2 2 2 2 2 2 2
D6S294 5 5 5 5 4 4 5 5 5 5 5 3
the 22 mutations found in the macular-dystrophy group.
This change, identified as a CrT change at codon 172,
results in an ArgrTrp change (hereafter designated
“172ArgrTrp”). This amino acid is located in the sec-
ond intradiskal loop of the protein. This loop is thought
to be the most important for the functioning of the pro-
tein, stabilizing the photoreceptor discs through hom-
ophilic or heterophilic interactions across the intradiskal
space, and associating covalently with ROM1.
The 172ArgrTrp mutation was found in 11 families
(1 of these families has previously been reported by Wells
et al. 1993). One additional family was found to have
an 172ArgrGln mutation segregating with disease (this
family also has previously been reported by Wells et al.
[1993]). The mutations carried by the other 10 families
are given in table 1.
Mutations at codon 172 have previously been re-
ported by Wroblewski et al. (1994) and Reig et al.
(1995); Wroblewski et al. described three families, two
with 172ArgrTrp mutations and one with a
172ArgrGln mutation, all giving rise to macular dys-
trophy, and Reig et al. described one Spanish family with
a 172ArgrTrp mutation causing central areolar cho-
roidal dystrophy. Two of these latter three families are
included in the present study. Phenotypic studies of pa-
tients with mutations at codon 172 have been performed
by Nakazawa et al. (1995), Wada et al. (1995), and
Piguet et al. (1996). All of these groups studied single
families and noted that the patients showed a charac-
teristic autosomal dominant macular phenotype. This
would suggest that, in addition to the 172ArgrTrp mu-
tation being due to a founder effect in the British pop-
ulation, mutations at codon 172 are not uncommon in
causing macular dystrophy.
We investigated whether this preponderance of the
mutation at codon 172 was the result of a founder effect
or was due to a mutational hotspot in the gene. Hap-
lotype analysis of these 12 families by means of six mi-
crosatellite repeat markers, distributed over a 20cM in-
terval around the RDS locus, showed remarkable
conservation of alleles between the families. Affected in-
dividuals share at least five of the alleles. The family
with a 172ArgrGln mutation was included as a control
in the analysis (table 2). The frequencies of the alleles
that constitute the disease haplotype in the British pop-
ulation are given in table 3. Both their low frequency
and the absence of this haplotype, in its entirety, in any
of our 50 controls (taken from the same population as
that containing the macular-dystrophy families) would
therefore support the conclusion that this mutation is
due to a founder effect. All 11 families are therefore
ancestrally related, with an initial mutation event oc-
curring many generations ago.
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Table 3
Allele Frequencies of Disease Haplotype in 50 Ethnically
Matched Controls from the British Caucasian Population
Marker
Allele of Disease
Haplotype
Frequency in Control
Population
D6S258 6 .21
D6S276 7 .22
D6S291 1 .2
D6S271 5 .18
D6S282 3 .12
D6S459 2 .11
D6S294 5 .11
Figure 1 Genetic positioning of RDS on chromosome 6p, based
on the recombinations seen in the families in the present study. (In-
formation from the National Center for Biotechnology, National In-
stitutes of Health)
Table 4
Recombination Events Enabling Genetic Positioning of RDS
Marker Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7
D6S258 6 6 6 6 6 3 3
D6S276 7 7 7 7 7 7 6
D6S291 1 1 1 1 1 1 2
D6S1552 3 3 3 3 3 3 1
D6S1582 3 3 3 3 3 3 4
RDS
D6S271 4 5 5 5 5 5 5
D6S282 2 3 3 3 3 3 3
D6S459 2 2 2 2 2 2 2
D6S294 4 4 4 5 5 5 5
NOTE.—Patients 1 and 2 are child and parent, respectively; patient 2 shows a recombination event
centromeric to the RDS gene, whereas patient 7 shows a telomeric crossover. By means of the disease
haplotype of the extended ancestral families, the RDS gene has been positioned between D6S1582 and
D6S271, a distance of 1.2 cM (CEPH data).
In addition, recombination events telomeric and cen-
tromeric to the RDS gene were observed in two separate
individuals, both with the 172ArgrTrp mutation; there-
fore, these two individuals do not share the complete
disease haplotype with the other individuals in these 11
families. This has enabled us to genetically localize the
RDS gene to a 1.2-cM region between D6S1582 and
D6S271 (table 4 and fig. 1).
We can therefore conclude that the most commonly
occurring peripherin/RDS mutation in the British pop-
ulation is the 172ArgrTrp mutation, and this is consis-
tent with the hypothesis of a founder effect. Prior to
identification of the 172ArgrTrp mutation, these 11
families had been referred separately with different di-
agnoses, including cone dystrophy, macular dystrophy,
and central areolar choroidal dystrophy. After review of
the clinical data, it was clear that these families shared
a common phenotype (S. M. Downes, unpublished
data). All had significant loss of central vision, with a
distinctive retinal appearance. This characteristic phe-
notype seen in these 11 families should alert the clinician
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to the possibility of a peripherin/RDS mutation at codon
172.
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Cystic Fibrosis Transmembrane-Conductance
Regulator Mutations among African Americans
To the Editor:
Cystic fibrosis (CF) is less common in African Americans
than in Caucasians of northern European descent, with
an estimated incidence of 1/15,300 (Hamosh et al., in
press), although the severity of the disease is comparable
across racial lines. Macek et al. (1997) recently reported
in the Journal the identification of several CF transmem-
brane conductance regulator (CFTR) mutations of note-
worthy prevalence in blacks. This information will help
clinical laboratories to improve the sensitivity of CF mu-
tation testing for African American patients.
We have identified a CFTR mutation in exon 7 in two
unrelated individuals of African American descent who
were not included in the study by Macek et al. The
mutation, DF311, results in the loss of a phenylalanine
residue in the fifth transmembrane domain of the CFTR
protein. One of our patients is a 4-year-old African
American female who presented, at age 7 mo, with hy-
pochloremic metabolic alkalosis and dehydration. She
was subsequently found to have sweat chloride values
on two occasions of 75 and 83 mEq/liter. Her lung dis-
ease is mild, with only slight peribronchial thickening
on chest x-ray, and she had Staphylococcus aureus in
her sputum at age 3 years. She is considered pancreatic
sufficient, on the basis of qualitative fecal fat analysis.
Without pancreatic-enzyme supplementation, she has
maintained a normal growth pattern, with height and
weight at the 50th percentile. Mutation testing deter-
mined her genotype to be DF508/DF311. The DF311
allele was first detected by the appearance of a distinct
heteroduplex pattern when PCR product encompassing
exon 7 was electrophoresed on 10% polyacrylamide.
The mutation was identified as DF311 by dideoxy se-
quencing. No additional DF311 alleles have been found
after a screening of a further 271 patient samples (˜8.5%
African American) at the University of North Carolina
in Chapel Hill.
The second patient was referred for genetic testing
because of abnormal fetal ultrasound findings. The pa-
tient was a 25-year-old (G2 P0 SAB1) African American.
An ultrasound performed at 17 wk gestation identified
a fetus with a Dandy-Walker malformation and an ech-
ogenic bowel. Follow-up ultrasound at 18.2 wk gesta-
tion confirmed the CNS abnormalities and a grade II
echogenic bowel. The patient was counseled with regard
to the numerous causes of Dandy-Walker malforma-
tions, as well as with regard to the causes of echogenic
bowel, including CF. The fetal karyotype was normal,
but maternal and fetal CF testing identified a hetero-
duplex pattern identical to the DF311 heterozygote pos-
